COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer

Overview of attention for article published in Frontiers in Genetics, September 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,610 followers.

RT @FrontGenetics: New Research: COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer:…

10 Sep 2022

Reply Repost Favourite

RT @FrontGenetics: New Research: COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer:…

10 Sep 2022

Reply Repost Favourite

New Research: COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer: Breast cancer is the malignant tumor with the highest incidence rate at present, and its incidence rate ranks first in the… https://t.c

10 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.